{"title":"Stretched Exponential Modeling Reveals Drug-Specific Kinetics in Human Engineered Skeletal Muscle","authors":"Mattias Luber,Bruno Schmelz,Christof Lenz,Timo Betz","doi":"10.1016/j.bpj.2026.11.006","DOIUrl":null,"url":null,"abstract":"Understanding muscle tissue is key not only for advancing our knowledge of human biophysical function, but also for describing pathological states, improving treatment and providing insights for drug development. While using excised tissue is an excellent way to study muscular function, human tissue donation remains severely restricted, forcing reliance on non-human models.\nThe past decade has seen a rise in 3D in-vitro models of human skeletal muscle. However, many current experimental approaches struggle with the high variability of primary cells or the limited translational relevance of murine lines. Furthermore, state-of-the-art functional analysis typically focuses on peak force, which overlooks critical kinetic information. In this study, we present a systematic approach to generate functional engineered skeletal muscle tissues (ESMs), measure their contraction force dynamics, and model these dynamics to extract the effects of standard pharmacological modulators.\nWithin 14 days, ESMs based on the human immortalized LHCN-M2 cell line mature into aligned, multinucleated myofibers expressing key sarcomeric markers and exhibiting robust excitation-contraction coupling. To decode these dynamics, we introduce a novel mathematical model based on stretched exponential functions. This framework accurately captures heterogeneous contraction and relaxation phases across diverse phenotypes using only six interpretable parameters.\nWe validated the platform’s sensitivity using a library of pharmacological modulators. Our kinetic modeling revealed distinct parameter fingerprints for different drug classes, highlighting specific changes in contraction kinetics that peak force alone could not detect. Additionally, proteomic profiling confirmed the presence of necessary drug targets and established the maturation state of the tissue. Together, this study provides a scalable, high-fidelity human platform for high-content screening of contractile kinetics and muscle biophysics.","PeriodicalId":8922,"journal":{"name":"Biophysical journal","volume":"4 1","pages":""},"PeriodicalIF":3.7000,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biophysical journal","FirstCategoryId":"99","ListUrlMain":"https://doi.org/10.1016/j.bpj.2026.11.006","RegionNum":3,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOPHYSICS","Score":null,"Total":0}
引用次数: 0
Abstract
Understanding muscle tissue is key not only for advancing our knowledge of human biophysical function, but also for describing pathological states, improving treatment and providing insights for drug development. While using excised tissue is an excellent way to study muscular function, human tissue donation remains severely restricted, forcing reliance on non-human models.
The past decade has seen a rise in 3D in-vitro models of human skeletal muscle. However, many current experimental approaches struggle with the high variability of primary cells or the limited translational relevance of murine lines. Furthermore, state-of-the-art functional analysis typically focuses on peak force, which overlooks critical kinetic information. In this study, we present a systematic approach to generate functional engineered skeletal muscle tissues (ESMs), measure their contraction force dynamics, and model these dynamics to extract the effects of standard pharmacological modulators.
Within 14 days, ESMs based on the human immortalized LHCN-M2 cell line mature into aligned, multinucleated myofibers expressing key sarcomeric markers and exhibiting robust excitation-contraction coupling. To decode these dynamics, we introduce a novel mathematical model based on stretched exponential functions. This framework accurately captures heterogeneous contraction and relaxation phases across diverse phenotypes using only six interpretable parameters.
We validated the platform’s sensitivity using a library of pharmacological modulators. Our kinetic modeling revealed distinct parameter fingerprints for different drug classes, highlighting specific changes in contraction kinetics that peak force alone could not detect. Additionally, proteomic profiling confirmed the presence of necessary drug targets and established the maturation state of the tissue. Together, this study provides a scalable, high-fidelity human platform for high-content screening of contractile kinetics and muscle biophysics.
期刊介绍:
BJ publishes original articles, letters, and perspectives on important problems in modern biophysics. The papers should be written so as to be of interest to a broad community of biophysicists. BJ welcomes experimental studies that employ quantitative physical approaches for the study of biological systems, including or spanning scales from molecule to whole organism. Experimental studies of a purely descriptive or phenomenological nature, with no theoretical or mechanistic underpinning, are not appropriate for publication in BJ. Theoretical studies should offer new insights into the understanding ofexperimental results or suggest new experimentally testable hypotheses. Articles reporting significant methodological or technological advances, which have potential to open new areas of biophysical investigation, are also suitable for publication in BJ. Papers describing improvements in accuracy or speed of existing methods or extra detail within methods described previously are not suitable for BJ.